Colon Cancer in-house Database (Atlantic Project) Enrico Capobianco Simone Carcangiu Massimiliano Orsini Antonella Travaglione Lucila Machado Kim Jihonn.

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Hereditary GI Cancer Syndromes: Keys to identify high risk patients
? BrCA at 44 BrCA at 51 BrCA at 58 Tom Example: Breast Cancer Sporadic Family clusters Hereditary 5%–10% 15%  20% An inherited predisposition.
1 An Update on Evolving Colorectal Screening Issues May 19, 2011 This first part today will be presented by: Stanley H. Weiss, MD, FACP, FACE  Professor,
Genetics of Gastrointestinal Neoplasia 张咸宁 Tel : ; Office: A709, Research Building 2012/04.
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
Risk Assessment for HNPCC
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Kalyani Maganti, M.D. ASCO Chromosomes, DNA, and Genes Cell Nucleus Chromosomes Gene Protein.
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
Colorectal Cancer Update Jonathan A. Laryea, MD FACS FASCRS FWACS Division of Colon & Rectal Surgery Department of Surgery University of Arkansas for Medical.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Introduction to Inheritance Sara Levene Registered Genetic Counsellor London IDEAS Genetic Knowledge Park.
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Colorectal Cancer Overview
Colon cancer By: Brittany Mares.
Screening and Early Diagnosis of Colorectal Cancer
 2 nd overall leading cause of cancer death in the United States › 3 rd in each sex  Approximately 6% of individuals in the US will develop a cancer.
Colorectal Cancer (CRC)
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
West Midlands Regional Genetics Laboratory
References 1.Salazar R, Roepman P, Capella G et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J.
Immunohistochemistry (IHC) for Microsatellite Instability Fact Sheet Frequently Asked Questions What is Lynch Syndrome? Lynch syndrome is a hereditary.
Cancer Genetics Genetic Disorder. What are cancer genetics? Many cancer-predisposing traits are inherited in an autosomal dominant fashion, that is, the.
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
Cancer Biology Ms. Sneha Singh Department of Zoology, DAVCG, Yamunanagar.
Colorectal carcinoma Dr.Mohammadzadeh.
The Effect of Celecoxib, a Cyclooxegenase-2 Inhibitor, In Familial Adenematous Polyposis Gideon Steinbach, M.D., Ph. D., Patrick Lynch, M.D., J.D., Robin.
Interventions for Clients with Colorectal Cancer
Cancer.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
 FAP - familial adenomatous polyposis  germline mutations in the APC gene (“gatekeeper”)  HNPCC - hereditary nonpolyposis colon cancer (a.k.a. Lynch.
Adult-Onset Disease The Example of Colon Cancer Summer, 2012.
Colorectal Cancer. Colorectal cancer - statistics Leading causes of cancer death in the US Male Female Lung – 31% Lung – 25% Prostate – 11% Breast – 11%
Change in bowel habits … 60 year old male Complains of progressive constipation for the past 6 months.
Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.
סרטן מעי גס אבחון מוקדם מניעה טיפול מונע ד"ר הוברט אילה מנהלת המרכז לגידולים במערכת העיכול מכון שרת הדסה עין כרם.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Uterine Cancer Endometrial (or uterine) cancer will account for 50,000 new cases and 8200 deaths in the United States in Two genetic disorders are.
MSH2 and Hereditary Nonpolyposis Colorectal Cancer By Bobby Glenn Warren III.
Slides last updated: March 2015 CRC: RISK FACTORS.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
Genomics A Systematic Study of the Locations, Functions and Interactions of Many Genes at Once.
Definition Signs & symptoms Treatment Root of the disease.
NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.
Genomics A Systematic Study of the Locations, Functions and Interactions of Many Genes at Once.
Care of Patients with Noninflammatory Intestinal D/O
Do you have 3 or more affected relatives? (2 or less)
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Pharmacogenomics: towards personalized medicine
Genomics A Systematic Study of the Locations, Functions and Interactions of Many Genes at Once.
Cancer Can Not Comfort But Your Family Can
MLH1 Mutations and the Formation of Hereditary Non-Polyposis Colon Cancer(Lynch Syndrome) Kevin Harris Hereditary Non-polyposis Colorectal Cancer (HNPCC)
A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.
Genomic Instability and Cancer
Hereditary and Familial Colon Cancer
Volume 130, Issue 2, Pages (February 2006)
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
Colonic polyps and tumors
Inflammatory Bowel Disease (IBD)
Familial Colorectal Cancer, Beyond Lynch Syndrome
Supporting Patients With Colorectal Cancer
MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.
Presentation transcript:

Colon Cancer in-house Database (Atlantic Project) Enrico Capobianco Simone Carcangiu Massimiliano Orsini Antonella Travaglione Lucila Machado Kim Jihonn Mark Epitzer

Goal Build up-to-date annotated transcriptome warehouse of colon cancer experimental data retrieved from the ArrayExpress db ….various filters apply…. Allow automated flow of gene expression data …

Array Express Transcripts by gene Expressions Raw Normalized DISEASEASSOCIATION CRC (colorectal cancer pilot study case)

Samples:  User-friendly complete annotation Genes:  Genome probe mapping Expressions:  Prediction/Classification Models Steps

Curation of the transcriptome warehouse Today Focus

Colon cancer, colorectal cancer, colorectal tumor… Array Express

Experimental information

Sample information

Inserire loro campi Sample annotation from our partners (GEO based)

Cell information Cancer information Patient information Risk factors Our sample annotation building blocks

Our sample fields 1. Cell information Organism : Homo sapiens Biosource provider : ATCC, DMSZ, DSMZ, ECACC ( Cell Lines Banks) Biosource type: fresh_sample, frozen_sample… Cell line/ Individual (identification code or sample name): SW480, HCT116… Cell type: colon epithelial… Genotype: wild_type… Phenotype: microsatellite instability (MSI-H) Genetically modified : gene_knock_in, gene_knock_out… Treated/ clinical treatment: DMSO.. Treatment type: in vivo, in vitro Treatment time: pre-operative/post-operative.. Time course : 4h…

Our sample fields 2. Cancer information - Organism part: colon, rectum, ascending colon, etc.. - Disease state: colon carcinoma, colon adenocarcinoma;colon cancer,metastasis; colorectal cancer, recurrence etc.. - Tumor size - Disease staging: duke's B primary, duke's C etc.. - Clinical history: high metastatic activity, low metastatic activity - Developmental Stage: adult, fetal

Our sample fields 3. Patient information - Age : Sex: female, male - Race/ ethnicity: Caucasian, African American, etc..

Our sample fields 4. Risk factors information - Family history - Recurrence - Past history of colon cancer - Crohn’s/ulcerative colitis - Diabetes - Smooking - Alcohol - Caffeine - FAP Familial adenomatous polyposis - HNPCC Hereditary Non-Polyposis Colon Cancer (Lynch Syndrome)

DB scheme

Genes:  Genome probe mapping Expressions:  Prediction/Classification Models Next Steps